Importantly, ADAM10 and/or ADAM17 sheddase activities have been shown to be highly upregulated on cancer cells, in cancer tissues and on circulating exosomes of cancer patients, and have demonstrated a considerable biomarker potentials 22, 26, 27. Here, ADAM17 is linked to cancer.